» Articles » PMID: 4040214

Human N-myc Gene Contributes to Neoplastic Transformation of Mammalian Cells in Culture

Overview
Journal Nature
Specialty Science
Date 1985 Jul 11
PMID 4040214
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Proto-oncogenes represent a group of eukaryotic genes whose activated forms are implicated in the development of cancer. We have recently identified a human gene, N-myc, that is distantly related to the proto-oncogene c-myc. N-myc is expressed at abnormally high levels consequent to amplification in numerous human neuroblastoma cell lines and metastatic neuroblastoma tumours. In addition, enhanced expression of N-myc, often a result of amplification, has been found in retinoblastoma cell lines and tumours (refs 5, 7 and M.S., unpublished data) and in cell lines derived from small-cell carcinomas of the lung. Here, we show that enhanced expression of N-myc subsequent to co-transfections of an N-myc expression vector and the mutant c-Ha-ras-1(EJ) (from the human bladder carcinoma cell line EJ) is a factor in tumorigenic conversion of secondary rat embryo cells. The transformed cells elicit tumours in athymic mice and isogeneic rats. The ability of N-myc to contribute to neoplastic transformation of cultured mammalian cells raises the possibility that enhanced expression consequent to amplification of N-myc may be a factor in the aetiology of human neuroblastoma.

Citing Articles

Want to quickly adapt to distorted speech and become a better listener? Read lips, not text.

Pourhashemi F, Baart M, van Laarhoven T, Vroomen J PLoS One. 2022; 17(12):e0278986.

PMID: 36580461 PMC: 9799298. DOI: 10.1371/journal.pone.0278986.


The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma Cells.

Sekhri P, Ledezma D, Shukla A, Sweeney E, Fernandes R Cancers (Basel). 2022; 14(6).

PMID: 35326601 PMC: 8945975. DOI: 10.3390/cancers14061447.


Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma.

Gao Y, Volegova M, Nasholm N, Das S, Kwiatkowski N, Abraham B Front Oncol. 2022; 11:773186.

PMID: 35198433 PMC: 8859926. DOI: 10.3389/fonc.2021.773186.


MYCN in Neuroblastoma: "Old Wine into New Wineskins".

Braoudaki M, Hatziagapiou K, Zaravinos A, Lambrou G Diseases. 2021; 9(4).

PMID: 34842635 PMC: 8628738. DOI: 10.3390/diseases9040078.


A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.

Perri P, Ponzoni M, Corrias M, Ceccherini I, Candiani S, Bachetti T Cancers (Basel). 2021; 13(21).

PMID: 34771690 PMC: 8582685. DOI: 10.3390/cancers13215528.